From: Antibiotic and anti-inflammatory use and the risk of prostate cancer
 | Cases (n = 65) | Controls (n = 195) | p value †|
---|---|---|---|
Current age | Â | Â | Â |
   ≤ 55 | 2 (3.1%)* | 6 (3.1%) | 0.98 |
   55–65 | 7 (10.8%) | 21 (10.8%) |  |
   65–75 | 17 (26.2%) | 51 (26.2%) |  |
   75–85 | 27 (41.5%) | 81 (41.5%) |  |
   85–95 | 11 (16.9%) | 33 (16.9%) |  |
   > 95 | 1 (1.5%) | 3 (1.5%) |  |
Race | Â | Â | Â |
   Asian or Pacific Islander | 3 (4.6%) | 9 (4.6%) | 1 |
   Black | 17 (26.2%) | 51 (26.2%) |  |
   Latino or Hispanic | 2 (3.1%) | 6 (3.1%) |  |
   White | 28 (43.1%) | 84 (43.1%) |  |
   Unknown | 15 (23.1%) | 45 (23.1%) |  |
Number of visits | Â | Â | Â |
   ≤ 50 | 7 (10.8%) | 44 (22.6%) | 0.01 |
   50–100 | 18 (27.7%) | 63 (32.3%) |  |
   100–150 | 20 (30.8%) | 48 (24.6%) |  |
   > 150 | 20 (30.8%) | 40 (20.5%) |  |
Years of enrollment | Â | Â | Â |
   ≤ 10 | 12 (18.5%) | 23 (11.8%) | 0.25 |
   10–15 | 16 (24.6%) | 55 (28.2%) |  |
   15–20 | 11 (16.9%) | 46 (23.6%) |  |
   > 20 | 26 (40.0%) | 71 (36.4%) |  |
History of prostatitis | 1 (1.54%) | 8 (4.1%) | 0.46 |
History of BPH | 41 (63.1%) | 114 (58.5%) | 0.56 |
Elevated PSA (>4.0) | 21 (32.3%) | 27 (13.9%) | <0.05 |
History of UTI | 57 (87.7%) | 151 (77.4%) | 0.08 |